In addition, researchers have suggested that the cholesterol metabolism disorder in the brain is involved in the pathogenesis of AD (14), and the polymorphism of genes that regulate the cholesterol metabolism, such as ABCA1 and APOE, increase the risk of AD (23). The gene discussed is ABCA1; the disease is Alzheimer disease.